News & Events
News & Events
June 22, 2018
2018 Clinical Outcome Assessments in Cancer Clinical Trials WorkshopWHAT: 2018 Clinical Outcome Assessments in Cancer Clinical Trials Workshop WHEN: June 22, 2018 WHERE: FDA White Oak Campus, Silver Spring, MD CONTENT: This full day workshop is sponsored by the FDA Oncology Center of Excellence and will consist of four panels made up of international regulatory, payer, academic, patient, industry and policy leaders. Initial agenda planning is...
- May 18, 2018
May 17, 2018
New Collaboration Seeks to Speed Huntington’s Disease Drug LicensingThis article originally appeared on HDBuzz and is reprinted here under Creative Commons license. Critical Path Institute launches new initiative to get HD drugs licensed as quickly as possible By Dr Jeff Carroll, Edited by Dr Ed Wild Originally published here on May 09, 2018 Recently the Critical Path Institute announced a new effort – the Huntington’s Disease...
May 14, 2018
Ninth Annual Patient-Reported Outcome Consortium WorkshopApril 25 – 26, 2018 Sheraton Silver Spring Hotel 8777 Georgia Avenue Silver Spring, MD 20910 On April 25-26, 2018 the NINTH ANNUAL PATIENT-REPORTED OUTCOME CONSORTIUM WORKSHOP was held in Silver Spring, Maryland. The overall Workshop objectives were to: Provide an update on FDA’s Clinical Outcome Assessment (COA) Qualification Program and address changes associated with...
May 7, 2018
C-Path Receives COA Qualification from FDA for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)TUCSON, Ariz. – May 7, 2018 — Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium announces its second clinical outcome assessment (COA) qualification from the US Food and Drug Administration (FDA). The qualification of the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ) for exploratory use represents another major milestone for the PRO Consortium and, specifically,...